Literature DB >> 6977576

A mitogen for human B cells: anti-Ig coupled to polyacrylamide beads activates blood mononuclear cells independently of T cells.

J J Fothergill, R Wistar, J N Woody, D C Parker.   

Abstract

The F(ab')2 fragment of rabbit anti-human F(ab')2 antibodies covalently linked to polyacrylamide beads (anti-Ig beads) acts as a polyclonal mitogen for human B cells in whole peripheral blood mononuclear cells (PBM) or tonsil cells. Activation, measured by the rate of DNA synthesis, is the result of an interaction between the anti-Ig beads and membrane immunoglobulin found on B cells. Excess soluble human F(ab')2 blocks activation with anti-Ig beads. Immunospecifically purified antibodies against IgM or IgD bound to beads activate lymphocytes. Also soluble anti-IgM or anti-IgD can block activation with insolubilized anti-IgM or anti-IgD, respectively, by modulating membrane immunoglobulin. Irrelevant rabbit antihapten antibodies bound to beads failed to activate PBM or tonsil cells. Anti-Ig beads act independently of T cells. The anti-Ig beads lead to activation of B cells without further maturation to polyclonal immunoglobulin secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Autocrine models of B-lymphocyte growth. I. Role of cell contact and soluble factors in T-independent B-cell responses.

Authors:  J Gordon; G Guy; L Walker
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

2.  Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation.

Authors:  T R Cupps; T L Gerrard; R J Falkoff; G Whalen; A S Fauci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Long-term growth of human B cells and their use in a microassay for B-cell growth factor.

Authors:  A L Maizel; J W Morgan; S R Mehta; N M Kouttab; J M Bator; C G Sahasrabuddhe
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

4.  B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus.

Authors:  H Becker; U Schauer; K Helmke
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

5.  Klebsiella pneumoniae stimulate highly purified human blood B cells to mature into plaque forming cells without prior proliferation.

Authors:  W L Gross; A Rucks
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

6.  X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.

Authors:  J L Sullivan; K S Byron; F E Brewster; S M Baker; H D Ochs
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

7.  T cell antiidiotypic antibodies reveal differences between two human leukemias.

Authors:  D N Posnett; R D Bigler; Y Bushkin; D E Fisher; C Y Wang; L F Mayer; N Chiorazzi; H G Kunkel
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

8.  Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies.

Authors:  S M Rudich; R Winchester; P K Mongini
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.